56 related articles for article (PubMed ID: 3290935)
21. Levetiracetam for manic behavior in hospitalized geriatric patients with dementia of the Alzheimer's type.
Kyomen HH; Whitfield TH; Baldessarini RJ
J Clin Psychopharmacol; 2007 Aug; 27(4):408-10. PubMed ID: 17632234
[No Abstract] [Full Text] [Related]
22. The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study.
Chiu CC; Su KP; Cheng TC; Liu HC; Chang CJ; Dewey ME; Stewart R; Huang SY
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1538-44. PubMed ID: 18573585
[TBL] [Abstract][Full Text] [Related]
23. Pilot study of antihypertensive treatment in the elderly.
Penman WA; Smith RG
Practitioner; 1982 Jun; 226(1368):1180-2. PubMed ID: 7050951
[No Abstract] [Full Text] [Related]
24. Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results.
Sparks DL; Sabbagh MN; Connor DJ; Lopez J; Launer LJ; Browne P; Wasser D; Johnson-Traver S; Lochhead J; Ziolwolski C
Arch Neurol; 2005 May; 62(5):753-7. PubMed ID: 15883262
[TBL] [Abstract][Full Text] [Related]
25. Risperidone and rivastigmine and agitated behaviour in severe Alzheimer's disease: a randomised double blind placebo controlled study.
Holmes C; Wilkinson D; Dean C; Clare C; El-Okl M; Hensford C; Moghul S
Int J Geriatr Psychiatry; 2007 Apr; 22(4):380-1. PubMed ID: 17380475
[No Abstract] [Full Text] [Related]
26. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
[TBL] [Abstract][Full Text] [Related]
27. Risperidone in the treatment of elderly patients with psychosis of Alzheimer's disease and related dementias.
Grossman F; Okamoto A; Turkoz I; Gharabawi G
J Am Geriatr Soc; 2004 May; 52(5):852-3. PubMed ID: 15086685
[No Abstract] [Full Text] [Related]
28. A pilot placebo-controlled study of chronic m-CPP administration in Alzheimer's disease.
Lawlor BA; Sunderland T; Mellow AM; Molchan SE; Martinez R; Murphy DL
Biol Psychiatry; 1991 Jul; 30(2):140-4. PubMed ID: 1912105
[TBL] [Abstract][Full Text] [Related]
29. Thyrotropin-releasing hormone (TRH) and Alzheimer's disease.
Peabody CA; Deblois TE; Tinklenberg JR
Am J Psychiatry; 1986 Feb; 143(2):262-3. PubMed ID: 3080909
[No Abstract] [Full Text] [Related]
30. Intravenous immunoglobulin for Alzheimer's disease.
Relkin N
Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):27-9. PubMed ID: 25546751
[No Abstract] [Full Text] [Related]
31. Bridging study of S12024 in 53 in-patients with Alzheimer's disease.
Allain H; Neuman E; Malbezin M; Salzman V; Guez D; Wesnes K; Gandon JM
J Am Geriatr Soc; 1997 Jan; 45(1):125-6. PubMed ID: 8994509
[No Abstract] [Full Text] [Related]
32. Alzheimer's disease. Using direct drug infusion to the central nervous system.
Reeder TM; Hohmann M
AORN J; 1986 Aug; 44(2):222, 224-30, 232. PubMed ID: 3530130
[No Abstract] [Full Text] [Related]
33. Evaluation of a new nutritional supplement for patients with Alzheimer's disease.
Riley ME; Volicer L
J Am Diet Assoc; 1990 Mar; 90(3):433-5. PubMed ID: 2307824
[No Abstract] [Full Text] [Related]
34. Tarenflurbil for Alzheimer's disease: a "shot on goal" that missed.
Vellas B
Lancet Neurol; 2010 Mar; 9(3):235-7. PubMed ID: 20170836
[No Abstract] [Full Text] [Related]
35. Clinical trials with novel treatments of Alzheimer's disease.
Spiegel R; Gray J
Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():410A-411A. PubMed ID: 1498894
[No Abstract] [Full Text] [Related]
36. The plain man's guide to research. The design.
Poswillo D
Br J Oral Maxillofac Surg; 1984 Oct; 22(5):322-7. PubMed ID: 6237667
[No Abstract] [Full Text] [Related]
37. A phase 1 open-label pilot study of low-dose interleukine-2 immunotherapy in patients with Alzheimer's disease.
Faridar A; Eid AM; Thome AD; Zhao W; Beers DR; Pascual MB; Nakawah MO; Roman GC; Davis CS; Grundman M; Masdeu JC; Appel SH
Transl Neurodegener; 2023 Nov; 12(1):54. PubMed ID: 37968718
[TBL] [Abstract][Full Text] [Related]
38. New treatments in Alzheimer's disease.
Pickrell WO; Robertson NP
J Neurol; 2018 Sep; 265(9):2162-2163. PubMed ID: 30132064
[No Abstract] [Full Text] [Related]
39. Neurotransmitter replacement therapy in Alzheimer's disease.
Mohr E; Mendis T; Rusk IN; Grimes JD
J Psychiatry Neurosci; 1994 Jan; 19(1):17-23. PubMed ID: 7908537
[TBL] [Abstract][Full Text] [Related]
40. A pilot study of serotonergic system responsivity in Alzheimer's disease.
Lawlor BA; Mellow AM; Sunderland T; Hill JL; Murphy DL
Psychopharmacol Bull; 1988; 24(1):127-9. PubMed ID: 3290935
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
